

| 카탈로그 번호 | DF879048 |
|---|---|
| 설명 |
Infliximab ELISA Kit (DF879048) — Quantitative sandwich ELISA for Infliximab. Sample: Plasma, Serum. Range: 0.31-5 μg/mL. Sensitivity: 0.156 μg/ml.
Highlights
|
| 샘플 유형 | Plasma, Serum |
| 민감도 | 0.156 μg/ml |
| 범위 | 0.31-5 μg/mL |
| 등록번호 | CAS: 170277-31-3 |
| 응용 분야 | ELISA |
| 검출 방법 | Colorimetric |
| 분석 유형 | Quantitative |
| 회수율 | 80-120% |
| 배송 | 2-8 ℃ |
| 안정성 및 저장 | The stability of ELISA kit is determined by the loss rate of activity. The loss rate of this kit is less than 10% prior to the expiration date under appropriate storage condition. |
| 사양 | Infliximab |
| 대체 이름 | TA-650, cA2, 170277-31-3 |
| 배경 | Infliximab is a chimeric monoclonal antibody and used to treat auto- immune disorders. Infliximab reduces the amount of active human tumour necrosis factor alpha (hTNFa) in the body by binding to it and preventing it from signaling the receptors for TNFa on the surface of various cell types. TNFa is one of the key cytokines that triggers and sustains the inflammatory reactions. Infliximab is used for the treatment of psoriasis, Crohn’s disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis. |
| 참고사항 | For Research Use Only. |
+86-027-65523339
중국 우한시 심둔사로 666번지 C동, 우한, 430206

中文
English
한국어
日本語
Español
Français
Русский